Document is current
Any future updates will be listed below
-
Authors
Lu, Bo
Klomjit, Nattawat
Zhu, Xiang-Yang
Jordan, Kyra L.
Grande, Joseph P.
Lerman, Lilach O. https://orcid.org/0000-0002-3271-3887
-
Funding
Funding for this research was provided by:
National Institutes of Health (DK120292, HL158691)
- License Information
-
More Information
Article History
Accepted: 5 June 2023
First Online: 13 June 2023
Declarations
:
: LOL is an advisor to AstraZeneca, CureSpec, and Ribocure-Pharmaceuticals.
: The human study was approved by the Mayo Clinic Institutional Review Board. The animal study was approved by the Mayo Clinic Institutional Animal Care and Use Committee.
: Informed consent was obtained.
: Not applicable.
